Health Rising welcomes corporate sponsors who support our mission to support people with chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID and related diseases. Sponsorships begin at $3,000 a year.
Please use our contact page to discuss becoming a corporate sponsor.
Our Sponsors
Open Medicine Foundation (OMF)

Boasting no less than three Nobel Prize Winners and six National Academy of Science members, the OMF’s Scientific Advisory Board is distinguished indeed. Health Rising thanks the OMF for it’s superb support over the years.
Learn more about the Open Medicine Foundation here.
The HHV-6 Foundation

Kristin Loomis, a mother of a child with ME/CFS, founded the HHV-6 Foundation. Daram Ablashi, the co-founder of the HHV-6 virus and the international organization of ME/CFS professionals, the IACFS/ME runs the HHV-6 Foundation’s scientific arm.
Prohealth
Prohealth was created by Rich Carson, a person with ME/CFS, in 1988 to provide high-quality supplements and products for people with ME/CFS, fibromyalgia, and similar disorders at an affordable cost.
Prohealth is more than a supplement company, however. With its blogs and Forums, Prohealth contains one of the largest information bases on ME/CFS on the internet. Prohealth’s commitment to producing breakthroughs for the ME/CFS community is exemplified in its decades-long decision to donate 10% of its profits to support ME/CFS research. Prohealth is a business with a purpose – supporting the eradication of ME/CFS/FM.
It was Rich Carson who spearheaded the successful drive to replace the term “chronic fatigue syndrome” with ME/CFS.
Prohealth and Rich Carson have generously supported Health Rising for many years.
Solve ME

Solve ME has a long history of funding breakthrough grants that catalyze myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid, and other post-infection disease research, and has an equally long history of advocacy efforts.
- Find out more about The Solve ME/CFS Initiative here.
Whittemore-Peterson Institute (Reno, Nevada)

The WPI saga began with Annette and Harvey Whittemore’s daughter’s severe case of ME/CFS and took root when the Nevada legislature approved $10 million in funding in 2005 for the 140,000 sq. ft. Center for Molecular Medicine, which included the Whittemore-Petterson Institute.
The WPI opened in 2010 as an ME/CFS clinic and research lab and was immediately swept up in the XMRV retrovirus finding. It was later determined that XMRV had been created years earlier when two mouse retroviruses combined in a different lab, and later showed up in ME/CFS and prostate cancer samples. Ultimately, we learned that XMRV can infect human cells but only in the lab.
While the XMRV saga did not lead to a breakthrough in ME/CFS, it did catalyze broad interest in ME/CFS and changed how retroviral work is done.
Beyond seeing patients and contributing funding to ME/CFS efforts, researchers working at the WPI uncovered a unique mucosal immune cell in ME/CFS, contributed insights into the gut’s role in these complex, chronic illnesses, identified a potential diagnostic biomarker, assessed peptide levels, and compared cytokine levels in ME/CFS and Gulf War Illness.
The WPI is currently looking for a new medical director.



